Evidence map›Paper›PMID 38867890›Full record

ArticleRegenerative biomaterials2024

Bone-targeted lipoplex-loaded three-dimensional bioprinting bilayer scaffold enhanced bone regeneration.

Woo-Jin Kim, Jeong-Hyun Ryu, Ji Won Kim, Ki-Tae Kim, Hye-Rim Shin, Heein Yoon, Hyun-Mo Ryoo, Young-Dan Cho

Abstract read
In one paragraph

Article in Regenerative biomaterials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Woo-Jin KimDepartment of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, 03080, Republic of Korea.
Jeong-Hyun RyuDepartment of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, 03080, Republic of Korea.
Ji Won KimDepartment of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, 03080, Republic of Korea.
Ki-Tae KimDepartment of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, 03080, Republic of Korea.
Hye-Rim ShinDepartment of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, 03080, Republic of Korea.
Heein YoonDepartment of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, 03080, Republic of Korea.
Hyun-Mo RyooDepartment of Molecular Genetics, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, 03080, Republic of Korea.ORCID https://orcid.org/0000-0001-6769-8341
Young-Dan ChoDepartment of Periodontology, School of Dentistry and Dental Research Institute, Seoul National University and Seoul National University Dental Hospital, Seoul, 03080, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical bone-morphogenetic protein 2 (BMP2) treatment for bone regeneration, often resulting in complications like soft tissue inflammation and ectopic ossification due to high dosages and non-specific delivery systems, necessitates research into improved biomaterials for better BMP2 stability and retention. To tackle this challenge, we introduced a groundbreaking bone-targeted, lipoplex-loaded, three-dimensional bioprinted bilayer scaffold, termed the polycaprolactone-bioink-nanoparticle (PBN) scaffold, aimed at boosting bone regeneration. We encapsulated BMP2 within the fibroin nanoparticle based lipoplex (Fibroplex) and functionalized it with DSS

Indexed as

3D bioprintingBMP2bone regenerationbone-targeting lipoplex

Identifiers

PMID38867890
PMCPMC11167398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.